The microchip, also called an embedded biosensor system, measures glucose concentration in diabetics. Digital Angel received U.S. approval for its patent last week. The company is seeking international patent protection.
"A glucose-sensing microchip could profoundly impact the 230 million people worldwide living with diabetes," McGrath said through a prepared statement. "We recognize that extensive work is required to commercialize this product, including the time and investment required for development, clinical trials and FDA approval. Still, we view this as an incredibly important advancement in the world of diabetes management."
"This is a landmark development in the world of diabetes management," Dr. Joseph Feldman, Chairman of the Emergency/Trauma Department of Hackensack University Medical Center, said through a prepared statement.
Most glucose monitoring kits use lancets, or pins, to draw blood. Earlier this year, Medtronic released wireless monitors that are coupled with insulin pumps, which deliver insulin through a small tube inserted under the skin. Those kits also use radio frequency technology.
Digital Angel produces electronic tags for livestock, pets, fish and humans. The company said its glucose-sensing microchip could monitor glucose levels in livestock as well.